For or against Adjuvant Trastuzumab for pT1a-bN0M0 Breast Cancer Patients with HER2-Positive Tumors: A Meta-Analysis of Published Literatures
2014 · PLoS ONE · 28 citations
https://doi.org/10.1371/journal.pone.0083646
Q
Qiong Zhou
Fudan University(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
756
Citations
15
h-index
20
i10-index
Qiong Zhou is an academic researcher from Fudan University. The author has contributed to research in topics: RNA modifications and cancer & HER2/EGFR in Cancer Research & Ferroptosis and cancer prognosis. The author has an h-index of 15, co-authored 37 publications.
ORCID: 0000-0002-8334-5527Papers by this author
worksFirst Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis
2012 · PLoS ONE · 24 citations
https://doi.org/10.1371/journal.pone.0032474
Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI
2021 · BMC Medical Imaging · 9 citations
https://doi.org/10.1186/s12880-021-00688-z
A novel single-cell model reveals ferroptosis-associated biomarkers for individualized therapy and prognostic prediction in hepatocellular carcinoma
2024 · BMC Biology · 8 citations
https://doi.org/10.1186/s12915-024-01931-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat